The Europe Digital Twins in Healthcare Market was valued at $935.4 Million in 2026 and projected to reach to $12747.6 Million by 2031, representing a compound annual growth rate of 68.6%. Europe's digital twins in healthcare market is poised for transformative growth through 2031, driven by substantial investments in healthcare digitalization and regulatory support for innovative medical technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's digital twins in healthcare market is projected to grow from $935.4 million in 2026 to $12,747.6 million by 2031, representing a robust 68.6% CAGR. This growth rate exceeds the global average of 68.4%, positioning Europe as a leading adopter of digital twin technologies in healthcare.
European healthcare institutions are increasingly investing in advanced digital twin solutions to enhance patient outcomes and optimize clinical operations. The region's regulatory framework and emphasis on innovation drive widespread adoption across hospitals, research centers, and medical device manufacturers.
Germany leads Europe's market with $7,269.4 million, followed by France ($6,589.4 million) and the UK ($5,685.1 million). These nations are spearheading digital twin implementation in personalized medicine, surgical planning, and hospital management systems.
European healthcare providers are leveraging digital twins for patient-specific treatment planning, medical device simulation, and predictive analytics. The technology is transforming cardiovascular care, oncology, orthopedics, and neurosurgery across the continent's leading medical institutions.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT (Application) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 68.4% from 2026 to 2031 |
| Largest Segment | SOFTWARE (Component) |
| Market Size Base Year (Billions) | ~USD 7.47 (2026) |
| Revenue Forecast (Billions) | ~USD 101.19 (2031) |
| Segments Covered | Component, Type, Application, End User |
4 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PROVIDERS | 20.15 | 33.37 | 55.52 | 92.77 | 155.7 | 262.48 | 442.45 | 745.76 | 68.1 |
| MEDICAL DEVICE COMPANIES | 9.93 | 16.55 | 27.69 | 46.53 | 78.54 | 133.15 | 225.72 | 382.6 | 69.1 |
| OTHER END USERS | 7.48 | 12.65 | 21.49 | 36.66 | 62.83 | 108.16 | 186.17 | 320.41 | 71.7 |
| PHARMA & BIOPHARMA COMPANIES | 14.19 | 23.76 | 39.97 | 67.53 | 114.59 | 195.32 | 332.89 | 567.29 | 70 |
| RESEARCH & ACADEMIA | 17.1 | 28.76 | 48.57 | 82.38 | 140.35 | 240.18 | 410.96 | 703.12 | 70.7 |
| TOTAL | 68.85 | 115.09 | 193.23 | 325.87 | 552.01 | 939.29 | 1598.2 | 2719.18 | 69.7 |
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PROVIDERS | 231.4 | 386.4 | 647.9 | 1091.5 | 1847.1 | 3125.8 | 5289.7 | 8967.4 | 69.1 |
| MEDICAL DEVICE COMPANIES | 89.5 | 149.7 | 251.4 | 424.3 | 719.3 | 1219.3 | 2066.9 | 3510.1 | 69.4 |
| OTHER END USERS | 106.9 | 176.5 | 292.7 | 487.5 | 815.5 | 1363.8 | 2280.5 | 3819.4 | 67.1 |
| PHARMA & BIOPHARMA COMPANIES | 168.4 | 282.1 | 474.9 | 802.9 | 1363.7 | 2316.3 | 3934.2 | 6694.2 | 69.8 |
| RESEARCH & ACADEMIA | 193.5 | 322.1 | 538.4 | 904.2 | 1525.2 | 2572.8 | 4339.9 | 7333.9 | 68.6 |
| TOTAL | 789.7 | 1316.8 | 2205.4 | 3710.4 | 6270.8 | 10598 | 17911.2 | 30324.9 | 68.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| MICROSOFT | United States | Public Company | Intelligent Cloud (Azure, Server, GitHub, Nuance),Productivity & Business Processes (Microsoft 365, LinkedIn, Dynamics),Personal Computing (Windows, Devices, Gaming, Search & Ads), |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems & Devices,Connected Care & Monitoring / Enterprise Informatics, |
| DASSAULT SYSTèMES | France | Public Company | 3D Modeling (CATIA, SOLIDWORKS, GEOVIA, BIOVIA),Social & Collaborative (ENOVIA, CENTRIC PLM, 3DEXCITE),Simulation & Manufacturing (SIMULIA, DELMIA, 3DVIA), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (including Ultrasound and IGT),Patient Care Solutions, |
| ORACLE | United States | Public Company | Cloud applications (Fusion ERP/EPM/SCM/HCM, NetSuite, Oracle Health, CX),Cloud and on-premise database and infrastructure technologies,Hardware products and related software/support, |
| IBM | United States | Public Company | Software (Hybrid Cloud & AI Platforms),Consulting (Strategy, Technology, Intelligent Operations),Infrastructure (Servers, Storage, Lifecycle Services), |
| PTC | United States | Public Company | PLM (Windchill, Arena, FlexPLM),CAD (Creo, Onshape),IoT & AR (ThingWorx, Kepware, Vuforia), |
| SAP | Germany | Public Company | SAP S/4HANA and core ERP,Human Experience Management (SAP SuccessFactors),Spend Management and Business Network, |
| ATOS SE | United States | Public Company | Infrastructure & Cloud Managed Services,Digital Workplace Solutions,Business & Platform Integration / Digital Transformation, |
| NVIDIA CORPORATION | United States | Public Company | Data Center Accelerated Computing & AI Platforms,Networking (High-speed interconnects and DPUs),Gaming GPUs (GeForce), |
| ANSYS INC. | United States | Private Company | Structural & Multiphysics (Ansys Mechanical, LS-DYNA, design exploration),Fluids (Ansys Fluent and related CFD tools),Electronics, Power & EDA (HFSS, RedHawk-SC, mission simulation, SCADE), |
Microsoft is a public technology company founded in 1975 with 228,000 employees, headquartered in the United States.
Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees specializing in healthcare technology and diagnostics.
Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees operating across healthcare, consumer electronics, and lighting sectors.
Dassault Systèmes is a French public company founded in 1981 with 25,724 employees providing 3D design and digital transformation software solutions.
GE Healthcare is a public healthcare technology company founded in 2022 with 54,000 employees providing medical imaging and diagnostic solutions.
Oracle is a public software and database company founded in 1977 with 141,000 employees headquartered in the United States.
IBM is a public technology and consulting company founded in 1911 with 264,300 employees providing enterprise software, hardware, and services.
PTC is a public software company founded in 1985 with 7,000 employees specializing in product lifecycle management and industrial IoT solutions.
SAP is a German public company founded in 1972 with 111,038 employees providing enterprise resource planning and business software solutions.
Atos SE is a public company founded in 1997 and based in the United States providing IT services and digital transformation solutions.
NVIDIA Corporation is a public technology company founded in 1993 with 42,000 employees specializing in graphics processing units and AI computing.
Ansys Inc. is a private software company founded in 1970 with 6,600 employees providing simulation and engineering software solutions.
| Country | 2025 size (native) |
|---|---|
| Germany | USD 7269.4 Million |
| UK | USD 5685.1 Million |
| France | USD 6589.4 Million |
| Italy | USD 3132.7 Million |
| Spain | USD 2682.8 Million |
| Rest of Europe | USD 4965.4 Million |
Europe's digital twins in healthcare market is valued at $935.4 million in 2026 and is projected to grow significantly through 2031.
Europe's digital twins in healthcare market is expected to grow at a CAGR of 68.6% from 2026 to 2031.
Europe is utilizing digital twins for surgical planning, drug development, personalized medicine, clinical workflow optimization, and patient outcome prediction across cardiology, oncology, and other specialties.
Europe's adoption is driven by advanced healthcare infrastructure, regulatory frameworks, precision medicine initiatives, R&D investments, and the presence of leading medical technology companies.
Europe's 68.6% CAGR closely aligns with the global 68.4% CAGR, positioning Europe as a key market with strong growth momentum and innovation leadership.
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, annual reports, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the digital twins in healthcare market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital twins in healthcare market. Primary sources from the demand side included personnel from hospitals (small, medium-sized, and large hospitals), diagnostic centers, and stakeholders in corporate & government bodies.

Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the digital twins in healthcare market was arrived at after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.

The size of the digital twins in healthcare market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows:
The total revenue in the digital twins in healthcare market was determined by extrapolating the market share data of major companies.
According to the Digital Twin Consortium, a digital twin is a virtual representation of real-world entities and processes synchronized at a specified frequency and fidelity. This allows end users to monitor what is happening inside the physical asset in real-time. By providing a holistic view of real-time behavior in a real-world environment mapped to a constantly updated virtual model, digital twins make it possible to anticipate maintenance needs, optimize performance, and avoid costly failures.
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
Geographic Analysis
Full forecast, segment splits, and company analysis for all Digital Twins in Healthcare Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report